Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

HHS-CDC-NCEZID Forecasted CDC-RFA-CK-26-0193

Description

The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of an association of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care. Social Determinants of Health impacts could be considered as well. Please note that applicants must apply for strategy number 1 (SHARE) and that strategies 2 (EDUCATE) and 3 (TRACK) are optional.

Eligibility

Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2

Funding Details

Award Floor: $25,000.00
Award Ceiling: $1,000,000.00
Total Estimated Funding: $10,000,000.00
Expected Awards: 3

Key Dates

Posted: December 10, 2025
Closes: N/A
Archive Date: May 31, 2026

Agency Information

Agency Name: HHS-CDC-NCEZID
Agency Code: HHS-CDC-NCEZID
Funding Instrument: Other

Apply on Grants.gov